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The Prevalence of Frailty and its association with clinical outcomes in General 
Surgery: A Systematic Review and Meta-Analysis. 
 
ABSTRACT 
 
OBJECTIVES: To investigate the prevalence and impact of frailty for general 
surgical patients. 
RESEARCH DESIGN AND METHODS: We conducted a systematic review and 
meta-analysis. Studies published between January 1st, 1980 and August 31st  2017 
were searched from 7 databases. Incidence of clinical outcomes (mortality at day 30 
and day 90; readmission at day 30, surgical complications and length of stay) were 
estimated by frailty subgroup (not-frail, pre-frail, and frail).  
RESULTS: 2281 participants from 9 observational studies were included, 49.3% 
(1013/2055) were male. Mean age ranged from 61 to 77 years old. Eight studies 
provided outcome data and were quality assessed and of fair or good quality, and 
one study only provided an estimate of prevalence and was not quality assessed. 
The prevalence estimate ranged between 31.3% to 45.8% for pre-frailty and 10.4% 
to 37.0% for frailty. After pooling, day 30 mortality was 8% (95% CI 4% to 12%; 
I2=0%) for frail compared to 1% for non-frail patients (95% CI 0 to 2%; I2=75%).  Due 
to heterogeneity the day 90 mortality was not pooled. Re-admission rates were lower 
in the non-frail groups but were not pooled. Complications for the frail patients were 
24%, (95% CI 20 to 31%;I2=92%), pre-frail subgroup  9% (95% CI 5 to 14%; I2=82%) 
and non-frail  5% (95% CI 3 to 7%; I2=70%). The mean length of stay in frail people 
was 9.6 days (95% CI 6.2 to 12.9) and 6.4 days (4.9 to 7.9) non-frail.  
CONCLUSIONS: Frailty is associated with adverse post-operative outcomes in 
general surgery. 
 
 
 
Background 
 
Frailty is a condition characterised by loss of biological reserves, failure of homeostatic 
mechanisms and vulnerability to adverse outcomes following stressor events such as 
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surgery. Delivery of surgical care becomes more challenging in this context (1). Faced 
with an ageing population whose rate of general surgical intervention is increasing 
rapidly, awareness of frailty is becoming more widespread in surgical and critical care 
settings (2). Similarly, the importance of the identification and management of the frail 
patient is increasingly being recognized. For example, the National Confidential 
Enquiry into Patient Outcome and Death, An Age Old Problem, highlighted 
substandard care for older surgical patients and recommended daily geriatrician 
clinical input for these patients (3).  
 
In medical settings it has been shown that frailty is present in 20-50% of the middle 
and older aged population, depending on the exact disease and the method of frailty 
measurement used(4). This review further demonstrated that mortality was higher 
across all specialties when frailty was present but that wide variation existed(4) . For 
example, one large study showed that frail people aged over 75 years admitted to 
hospital had an odds ratio of 1.6 for death regardless of diagnosis. (5). This is much 
higher than a Swedish community study which demonstrated an increased hazard 
ratio for all cause mortality of 1.07 for older frail people(6). 
 
Although a modest but increasing number of studies have recently assessed a number 
of different frailty tools in both emergency and elective general surgery against a range 
of outcomes, no systematic reviews have yet attempted to give an overview of the 
impact of frailty for people undergoing general surgery. Hence, the aim of this review 
was to assess frailty prevalence and its association with clinical outcomes (death, 
readmission to hospital, complications and length of hospital stay) within general 
surgery. 
 
Methods 
This systematic review was reported within the PRISMA framework. The review was 
registered and the protocol is available on Research Registry (reviewregistry129, 
http://www.researchregistry.com) 
 
Search strategy 
The search strategy was developed by an expert research support librarian at the 
University of Leeds, in full collaboration with the review team. We searched seven  
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electronic databases (Medline, CINAHL, The Cochrane Library, AMED, PSYCINFO, 
EMBASE and Web of Science) for manuscripts published from January 1st, 1980, to 
August 31st, 2017. All identified and relevant studies’ references were manually 
reviewed to identify any potential studies that met the inclusion criteria. The included 
studies underwent a forward citation search to identify any future studies which may 
have referenced them. The search terms were based on MeSH terms (Medical Subject 
Headings) and other controlled vocabulary.  Search terms relating to surgery, frailty 
and risk factors were used.  The search strategy is outlined in supplementary file 1.   
 
Eligibility criteria and study identification 
The review process is summarised in a PRISMA flow diagram (Figure 1). 
Randomized controlled trials, cohort studies and case-control study designs were 
eligible for inclusion. Only studies using a validated method of frailty identification were 
included (7). Studies that used large scale database analysis assessing frailty and 
surgery were excluded (8). Studies based solely in intensive care were excluded since 
these populations are atypical and could introduce additional confounders. No 
language restrictions were applied 
 
Two reviewers (JH, SL) searched the literature and assessed the studies for eligibility 
independently. Disagreements were resolved through discussion with a third reviewer 
(BC).  
 
Data extraction and quality assessment  
Demographic information, frailty tool, frailty prevalence and outcomes data were 
extracted from the included studies independently by two reviewers (JH, SL) 
disagreements were resolved through discussion with a third reviewer (BC). 
Study authors were contacted to clarify or provide additional data where it was missing 
or unclear. 
For the studies included the quality assessment was conducted by two reviewers 
independently (JH, SL) and arbitrated by a third (BC) using the Newcastle-Ottawa 
Scale (NOS) (9, 10), which assesses the risk of bias of observational studies. Each 
domain examined was determined as good, fair or poor. Studies were deemed to be 
of good quality where they scored good for all domains, fair if they scored fair in one 
or more domain and likewise poor if they scored poor in any one domain.  
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Data analysis 
Frailty prevalence was estimated using studies that had categorized frailty using 
standard specific cut-offs for validated frailty tools (11-15). For consistency, prevalence 
was not calculated using studies where participants were defined as being frail using 
a non-standard cut-off. 
 
Data were extracted for the following primary outcomes: short term mortality (30 day), 
and medium term (90 to 180 days months) mortality. Further data were extracted for 
the following secondary outcomes: 30 day readmission to hospital, complications and 
length of hospital stay. All outcomes captured dichotomous data except for the length 
of stay, and the treatment effects were measured by the proportion of patients 
experiencing the outcome. Continuous data for the length of stay were skewed, so 
were transformed and summary statistics were calculated on the transformed scale. 
Frailty subgroups were used to explore the association between frailty and outcomes. 
If study design and population did not exhibit clinical heterogeneity, data were pooled 
in a random effects meta-analysis. All meta-analyses were conducted using Stata 
version 13.0.  
 
Assessment of subgroups and statistical heterogeneity 
Heterogeneity was assessed using the I2 statistic, and pooling that exhibited an I2 over 
85% was explored using subgroup analyses. All meta-analyses were presented as an 
estimated proportion, associated 95% confidence interval (95% CI), P-values and I2 
summary data. Frailty was a pre-specified subgroup to explore the association 
between frailty and outcomes. Patients were categorized as non-frail, pre-frail or frail. 
The following pre-specified subgroups were used to explain heterogeneity: quality 
assessment (high quality, versus unclear and low quality studies); age of patients (65 
to 70; 70 to 80; 80+); type of surgery (elective; emergency; or combined). 
 
Results 
Identified studies and quality assessment 
After removal of duplicates, 7588 records were identified, and led to 33 full texts being 
reviewed, where 24 were excluded. Nine were included in this analysis and are shown 
in the PRISMA flowchart (Figure 1) (16-24). One study only considered frailty 
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prevalence (16), and was excluded and not assessed for quality. This study was not 
considered in the meta-analysis or the quality assessment (Supplementary Table 1). 
Five studies were determined as good quality (17, 18, 20, 23, 24) three were 
categorized as fair quality (19, 21, 25) and none were categorized as poor quality. The 
average NOS score was 8.3. For further details of the results of the quality assessment 
tool, see Supplementary Tables 1A and 1B. 
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Figure 1: PRISMA Flowchart of included studies  
 
 
 
  
Records identified through database 
searching 
(n =11827  ) 
Additional records identified through 
other sources 
(n = 0 ) 
Records after duplicates removed 
(n = 7588) 
Following search, records 
screened (n = 96) 
 Records excluded as not 
relevant  
(n =63) 
Full-text articles assessed 
for eligibility 
(n = 33)  
Full-text articles excluded, 
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(n =24) 
Not appropriate surgical 
specialties (patients not 
general surgical) (6) 
Not appropriate study 
design (2) 
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used (6) 
Additional Studies based on 
those already included (9) 
Focused on cost analysis (1) 
  
Studies included in 
synthesis of prevalence 
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(n = 9  ) 
Studies included in outcome 
synthesis and quality assessed 
(meta-analysis) 
(n = 8) 
Excluded: 
Prevalence Only 
Study (n=1) 
 Records excluded at title 
stage 
(n =7492) 
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Characteristics of the included studies 
From the 9 studies 2281 patients were included, 49.3% were male (1013/2055) and 
six studies only recruited older patients (over 65 year olds)., tThe mean age ranged 
from 61 to 77 years old (Table 1). 
Frailty Prevalence 
The 9 included studies used a range of frailty assessment tools, of which seven were 
deemed suitable for inclusion in the prevalence estimation. One study (23) 
oversampled complex cases, as such it was not a representative sample to be 
included in the prevalence data. The other excluded study used a range of frailty 
scales and was not suitable for inclusion (19). Of the included studies, two used the 
phenotype model (16, 20), two the Groningen Frailty Indicator (21, 24), two the deficit 
based model (17, 18)and one a seven point assessment of frailty traits (25). The 
prevalence of pre-frail ranged between 31.3%-45.8%, frailty prevalence ranged 
between 10.4%-37.0%. The included studies and the prevalence estimated are shown 
in Supplementary Table 2. 
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Author  Year 
Countr
y 
Population Details 
No. 
patients 
Age*** 
Sex  
(%)(M:F) 
Frailty 
indexMeasure 
Quality 
assess
ments 
Chen C 2015 Taiwan 
Elective abdominal surgery 
(Upper Abdominal=147, lower 
abdominal 232) , expected 
LOS >6 days and able to 
communicate 
379 
>65yr 
74.5 ± 
5.9 SD 
216 
(57.0) 
163 
(43.0) 
5 Point Phenotype 
Model 
NA 
Hewitt J 2014 UK 
Emergency general surgery 
admissions (upper and lower 
abdominal surgery), older 
patients. Not all patients 
underwent surgery 
325 
>65yr 
77.3 (65-
101) 
140 
(43.1) 
185 
(56.9) 
CHSA 7 point scale 
(deficit derived) 
Good 
Joseph B 2014 USA 
Emergency General Surgery 
(all underwent surgery), older 
patients 
220 
>65yr 
75.5 ± 
7.7cSD 
123 
(55.9) 
97 (44.1) 
DAI 50 variables, 
>0.25 = frail 
Good 
Kenig J 
2015 
(2) 
Poland 
Emergency abdominal 
surgery, tertiary referral centre, 
operated within 24 hours 
184 
>65yr 
76.9 ± 
5.8 (65–
100) 
86 (46.7) 
98 (53.3) 
VES-13 (>=3), 
TRST (>=1), G8 
(<=14), GFI (>=4), 
Rockwood (>=2), 
Balducci (1) 
Fair 
Makary 
M 
2010 USA 
Elective surgery recruited from 
a pre-assessment centre, 
older patients 
594 
>65yr, 
71.3 (65-
94) 
236 
(39.7) 
358 
(60.3) 
5 Point Phenotype 
Model 
Good 
Reisinger 
K 
2015 
Netherl
ands 
Emergency and elective 
colorectal cancer surgery, non-
academic centre  
154* >70yr 
Not 
stated 
Groningen Frailty 
Indicator (>=5) 
Fair 
Robinson 
T 
2013 US 
Elective Colorectal Surgery, all 
surgery performed after at 
least 72 hours after 
presentation to hospital. 
201 
>65yr 74 
± 6 SD  
Not 
stated 
7 Domain based 
scoring system 
Fair 
Saxton A 2011 US 
Elective General Surgery, 
Older Patients 
226 
No age 
cut off. 
61 ± 13 
SD 
106 
(46.9) 
120 
(53.1) 
CHSA 70 point 
deficit model, >0.12 
taken as frail 
Good 
Tegels J 2014 
Netherl
ands 
Elective Gastric 
Adenocarcinoma Cancer 
surgery, in a community 
teaching hospital. 
127** 
No age 
cut off. 
69.8 (73-
88) 
106 
(58.9) 
74 (41.1) 
Groningen Frailty 
Indicator (>=3) 
Good 
Table 1, Included Studies, all are observational (*only patients aged over 70 were assessed for frailty,  **  patients with complete frailty 
data, *** Range unless stated as Standard Deviation (SD)) 
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Short term mortality (Day 30), and medium term mortality (Day 90 to Day 180).  
Three studies reported mortality at Day 30 (17, 18, 21), this included 9% (17/192) 
patients who were determined as frail, and 3% (12/479) who were non-frail. After 
pooling, the proportion who were frail was 8% (95% CI 4% to 12%; I2=0%), which 
compared to 1% of non-frail patients (95% CI 0 to 2%; I2=75%, Figure 2).  
Two studies reported mortality in the medium term (17, 24), 23% (24/105) died who 
were frail, compared to 11% (34/300) who were not frail (Figure 3). Pooling was not 
possible due to severe heterogeneity, and caution is needed in the interpretation of 
the two subgroups (Figure 3). 
 
Readmission at Day 30 
Two studies reported the proportion of patients with a re-admission(17, 25) One study 
found the proportion who were re-admitted was 14% in both the frail and the non-frail 
groups(17) and the second 29% in the frail group, compared to  7% in the non-frail 
group(25).  
Surgical Complications  
Four studies reported the proportion of patients who suffered surgical complications 
(18, 20, 21, 25). Severe clinical heterogeneity was exhibited between the studies, 
which was explained in part by frailty. The estimated proportion to exhibit complications 
from the frail subgroup of patients was 24%, (95% CI 20% to 31%;I2=92%, Figure 
4Supplementary Table 1) pre-frail subgroup  9% (95% CI 5% to 14%; I2=82%); and 
from the not-frail subgroup  5% (95% CI 3% to 7%; I2=70%). Post-operative 
complications were  assessed using a variety of tools, including the Accordion Severity 
Classification(25), the American College of Surgeons National Surgical Improvement 
Program definitions(18, 20)and those constructed directly by the study authors(21) 
Length of Stay 
Four studies presented data on the length of stay and applied cut offs for participants 
as either frail, or non-frail (17, 18, 24, 25). The pooled mean length of stay in frail 
people was 9.6 days (95% CI 6.2 to 12.9) and in those who were non-frail was 6.4 
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days (4.9 to 7.9), see Supplementary Figure 21. However, substantial heterogeneity 
was found within both of the frailty subgroups that was not able to be explained.   
Sensitivity analyses and pre-specified subgroups used to explain the 
heterogeneity 
Due to the few numbers of included studies no sensitivity analyses were carried out. 
Apart from the subgroups stated explicitly stated above, none of the other pre-
specified subgroup were able to explain the heterogeneity exhibited in the pooled 
meta-analyses.  
Discussion  
This study identified 9 studies, of which 8 were included in the analyses and were 
quality assessed. The studies covered a wide range of upper and lower abdominal 
surgical conditions, including both benign and malignant conditions, five of which were 
good quality and the remaining three fair quality.   
We found evidence of an increase in the proportion of patients that suffered mortality 
and surgical complications in those that were frail, compared to those patients who 
were not frail. Analysis identified short term (up to 30 day) mortality to be more frequent 
in those people who were frail. Post-operative complications were more frequent and 
length of hospital stay longer in frail individuals following their surgical illness. 
This review is the first review to characterize frailty in a general surgery patient group. 
Other recent reviews, whilst also demonstrating that frailty was associated with post-
operative complications examined studies from a range of surgical specialties, not 
solely general surgery: for example Lin and colleagues (26) and the narrative review 
by Beggs et al (27). This review also differs as it considers eight studies for meta-
analysis. Lin et al identified three general surgical articles for review but did not perform 
meta-analysis(26). Of the three studies which were considered by those authors, two 
(17, 19) are considered in this review and one (28) was excluded as the frailty 
assessment tool used was constructed by the study authors. However, our population 
did still contain some heterogeneity such as a range of age and both elective and 
emergency cases which may have confounded the overall association with 30 day 
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mortality and increased post operative complications that was demonstrated in this 
review. 
 
Strengths and weaknesses  
All of the studies included were of at least moderate quality, with more than half being 
judged as good quality. Due to the non-randomised nature of the included studies a 
combination of selection bias, performance bias, confounding and reporting bias is 
possible so the findings of this review should be viewed with caution. The specific 
biases associated with the studies were varied however, they include a poor 
description of the data collection methods and the non-frail comparator groups and in 
one(22) a very large male prevalence of the study participants. The degree to which 
these affect the overall finding is hard to determine but does need to be noted. Further, 
due to the non-randomised nature of the included studies the findings of this review 
should be viewed with caution Since the included study designs were cross-sectional, 
we took a conservative approach by comparing proportions, rather than estimating the 
increased relative risk of those with  increased frailty.  
However, a strength of the evidence linking frailty to poorer outcomes is consistentcy, 
with little heterogeneity demonstrated in most outcomes. The findings also suggest a 
dose-response of poorer outcomes linked to the presence of frailty when compared 
with the pre-frail subgroup, although we acknowledge that the pre-frail group was 
comprised of a comparatively small number of participants. The biological plausibility 
and a reasonable consistency across the varying studies is indicative that frailty is 
linked with poorer post-surgical outcomes.  
There was heterogeneity found within the post-operative complications outcomes, but 
we believe that this was introduced by differing methods used to assess post-operative 
complications. For example two studies (18, 20) used the  American College of 
Surgery National Surgical Quality Improvement Program definition, one (25) the 
American Society Guidelines and another(21) defined their own list of post-operative 
complications. Future studies should consider using a standardised post-operative 
complication definition, as this will aid accurate comparison between frail surgical 
patients across studies. 
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The quantity of robust published data for individual outcomes was limited. None of the 
preselected outcome measures were reported in more than four studies and two 
(medium term mortality and readmission to hospital) were only reported in two studies. 
Using small numbers of studies for meta-analysis requires a degree of caution when 
interpreting results, but throughout all of the outcomes there is a consistent and 
repeated effect of frailty.   
 
A potential limitation was the absence of data from patients with special clinical 
situations such as intensive care admission. The decision was taken to exclude these 
data to avoid introducing confounding. However, it should be noted as a potential area 
for future dedicated systematic review in light of evidence that frailty predicts risk of 
institutionalisation in surgical patients who are admitted to intensive care (12).   
 
The present review found a range of frailty assessment tools were chosen and 
implemented across the studies which will have introduced heterogeneity. This is to 
be expected as there are two broad models used for frailty assessment, the phenotype 
model and the accumulation of deficits model. Both models are valid and can be 
applied to research and clinical situations with the proviso that staff using these tools 
are trained in their use (29).  The search criteria in this review stated that we would 
only include studies that employed recognized frailty assessment methods. Eight of 
the included studies used either phenotype or deficit accumulation models. The only 
caution and deviation from the inclusion criteria was the decision to include the study 
by Robinson et al (25). This study did not use an established frailty assessment tool 
which conformed to either of the models described above. However, the primary 
author and the associated team have published widely in the field of surgical disease 
in the older person and the assessment tool they use is robust, validated and is being 
used by additional research groups. Therefore, following consensus, it was decided to 
include this study.  
  
It is also of note that one study (24) met our inclusion criteria but did not form part of 
the analysis. It was not possible to extract data from those contained in the manuscript. 
No response was received from the study authors for a more detailed breakdown of 
data which may have been usable. Should future studies wish to revisit this area, 
perhaps to address a different outcome, these data need to be included for 
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completeness. The findings of the study were all in keeping with the reported meta-
analysis and frailty showed an association with morbidity (p=0.02). 
 
Additionally we excluded large database type assessments of frailty(8) from our 
analysis. The primary rationale was twohree fold. Firstly, these studies used frailty 
assessments derived specifically for each database according to the factors available 
within them and were not uniform in construction and. Ssecondly, they were of such 
scale that to have included them would have influenced the results to such an extent 
that other smaller studies would have had virtually no effect on the outcome measures 
generated. and thirdly none of them used assessments that are used in clinical 
practice, limiting their day to day utility.  
 
Implications for research and clinical practice 
All of the included studies were published since 2010, and it is likely that further studies 
will be suitable for combination with the data shown here to further reinforce (or 
repudiate) our findings. Perhaps more importantly, it is likely that additional outcome 
data will become available for measures such as long term mortality, and for patient-
facing measures such as quality of life after surgery and requirement for social care 
provision. Further research in these areas will allow more comprehensive assessment 
of the impact that surgical conditions and their management have on frail patients.  
  
By establishing the impact of frailty on both morbidity and mortality, this study further 
highlights the importance of this clinical condition. Clinicians can use the presence of 
frailty to help predict worse outcomes in general surgery. Where possible frailty should 
be identified pre-operatively, allowing the use of targeted interventions such as 
Comprehensive Geriatric Assessment (30, 31) with the aim of optimizing clinical 
condition prior to surgical management.  
Conclusions  
This study demonstrated that frailty is common in both elective and emergency general 
surgery. Despite a limited number of studies included in each of the meta-analyses 
frailty demonstrated a consistent association with both mortality and morbidity.  
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Figure 2 – Mortality at Day 30  
  
Frail
Hewitt, 2015
Joseph, 2016
Reisinger K, 2015
Subtotal  (I-squared = 0.0%, p = 0.987)
Not-Frail
Hewitt, 2015
Joseph, 2016
Reisinger K, 2015
Subtotal  (I-squared = 74.5%, p = 0.020)
ID
Study
0.08 (0.03, 0.16)
0.09 (0.04, 0.17)
0.08 (0.02, 0.21)
0.08 (0.04, 0.12)
0.02 (0.00, 0.04)
0.00 (0.00, 0.03)
0.07 (0.03, 0.13)
0.01 (-0.00, 0.02)
ES (95% CI)
43.60
38.19
18.22
100.00
31.05
64.55
4.39
100.00
Weight
%
  
0 .1 .2 .3 .4
By Frailty Group
Forest Plot for Incidence of Day 30 Mortality
16 
 
Figure 3 Mortality at Day 90 to 180  
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Figure 4 – The proportion of patients who suffer complications following surgery, by 
frailty  
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